News ArchivesRead News

Parkinson's treated with Victorian era device

Tuesday April 24, 2012

Will Parker

Science a Go Go - A 19th century "vibration chair" has been found by Rush University researchers to significantly improve some of the symptoms of Parkinson's disease. The chair was designed by French anatomist Jean-Martin Charcot (pictured), who is often referred to as the father of modern day neurology. At the time, Charcot reported improvements in his patients, but he died before more complete evaluations could be completed. The Rush researchers set out to replicate his work to see if his claims hold true against modern scientific testing.

Charcot originally noted that his patients reported that during long carriage rides or train journeys, the uncomfortable or painful symptoms of Parkinson's disease seemed to disappear, and the relief lasted quite some time after the journey. Acting on these anecdotes, he developed a chair that mimicked the continuous jerking of a carriage or train.

For the modern day assessment, lead researcher Christopher G. Goetz randomly assigned 23 patients to either a vibrating chair or the same chair without vibration. During the treatment sessions, both groups of study participants listened to a relaxation CD of nature sounds. The study participants underwent daily treatment for a month. "We attempted to mimic Charcot's protocol with modern equipment in order to confirm or refute an historical observation," explained Goetz.

Reporting his findings in the Journal of Parkinson's Disease, Goetz noted that the patients in the vibration group showed significant improvement in motor function after daily 30-minute treatments. However, motor function scores for the no vibration group also improved significantly.

"Our results confirm Charcot's observation of improvement in Parkinson's disease with chronic vibration treatment, but we did not find the effect specific to vibration," said Goetz. "Instead, our data suggest that auditory sensory stimulation with relaxation in a lounge chair or simply the participation in a research protocol has equivalent benefit as vibration on motor function."

Despite the indication that the effect is due to placebo or other nonspecific factors, Goetz says the findings are still of value. "Our results will allow clinicians to guide patients to at least one apparatus that is safe and associated with objective changes in parkinsonian impairment scores," he concluded.


Recent News

Nov 22 - A caregiver's story: Living and loving through the slow process of dying
Nov 19 - Testosterone cause of sex differences in the occurrence of Parkinson’s disease, new research suggests
Nov 18 - New strategy reduces side effects in Parkinson's treatment
Nov 14 - Opinion: The never-ending tests of Parkinson's disease
Nov 13 - Parkinson’s disease: A new tool for diagnosis
Nov 10 - Parkinson's Disease Drug May Be Useful For Delaying, Preventing Blindness In Older Population
Nov 9 - Microsoft VP’s diagnosis fuels employees’ heartfelt efforts to help others
Nov 6 - Lewy body dementia: unrecognized and misdiagnosed
Nov 5 - Gait difficulties in Parkinson's linked to new blood vessels in brain
Oct 30 - Special Section: Enabling Technologies for Parkinson’s Disease Management
Oct 27 - Scientists discover a 'switchboard' of molecules that protect against Parkinson's disease
Oct 26 - Dancing improves mobility and quality of life in people with Parkinson's
Oct 23 - The amazing woman who can smell Parkinson’s disease — before symptoms appear
Oct 20 - Personal Essay: The deviousness of dementia
Oct 19 - Mechanism that 'melts' protein clumps may lead to new Parkinson's treatments
Oct 19 - Researchers find that stem cell treatment may reduce cognitive impairment related to dementia with Lewy bodies
Oct 17 - Cancer Drug Helps Parkinson's Patients
Oct 12 - Researchers identify immune gene that can prevent Parkinson's disease and dementia
Oct 12 - Blog Post: An Alert, Well-Hydrated Artist in No Acute Distress
Oct 7 - This month, a brain surgery will be broadcast on live TV for the first time ever